Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03343873Recruiting
Open-label trial of midazolam, propofol injection (veterinary) and dexmedetomidine (3 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: Amplitude of Low Frequency Fluctuations and Regional Homogeneity. Started Apr 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03343873.